Sector News

Clariant to acquire a part of Vivimed Labs' personal care portfolio

October 1, 2015
Chemical Value Chain

The acquisition will support Clariant’s strategy to grow its presence in emerging markets and strengthen its product portfolio in personal care segment

Swiss specialty chemicals major Clariant on September 29, 2015 entered into an agreement to acquire a part of Vivimed Labs Limited’s personal care portfolio. The acquisition will enable Clariant India Ltd (a wholly-owned subsidiary of Clariant Group) to strengthen its personal care portfolio within the industrial & consumer specialties (ICS) business, by offering a wider product portfolio within the sun, skin, hair and oral care range as well as anti-microbial preservatives.

“The personal care industry in India offers us immense potential supported by the growing middle-class consumer population and the rising disposable income. This strategic decision will be a significant step towards strengthening our product portfolio and thereby reinforcing Clariant’s long term commitment in the segment. We believe in the growth potential that India offers and are focussed on expanding our footprint in the region,” commented Dr Deepak Parikh, region president – India, Middle East and Africa, Clariant.

Stephen Lynen, head ICS, Asia Pacific, Clariant, said, “This marks an important step of our global strategy to enhance our offering in personal care and to boost our presence in Asia. The transaction will strengthen our portfolio with actives to formulate broader solutions such as sun protection in a strong growing market – India.”

This acquisition will enable Clariant to expand its footprint and provide its customers with end-to-end solutions in sync with the current industry trends. “The strong growth perspective of the personal care industry results in a bright future for the ICS business in India,” added R Kumaresan, head of Clariant’s BU ICS, India.

Santosh Varalwar, MD & CEO, Vivimed Labs Limited, said, “I am pleased to announce an important strategic development at Vivimed. This transaction will help us significantly improve our financial flexibility for future growth. We are confident that this transaction, once completed, will position Vivimed optimally to move to the next level of growth, across its specialty chemicals and pharmaceuticals businesses.”

Clariant India operates in four business areas – care chemicals, catalysis & energy, natural resources, and plastics & coatings, including businesses like pigments (coatings, printing and plastics and special applications), additives, industrial & consumer specialties, mining services and masterbatches. In 2014, Clariant invested in a regional innovation centre in Mumbai, with an aim to co-create tailor-made solutions with customers for the industry.

Source: Business Standard

comments closed

Related News

December 5, 2021

Armand Ajdari appointed Chief Technology Officer

Chemical Value Chain

Effective from 1 January 2022, Armand Ajdari will be joining Arkema as the Group’s Chief Technology Officer. He will report to Thierry Le Hénaff, Chairman and CEO, and will be a member of the Group management committee.

December 5, 2021

Styrolution to build advanced-recycling pilot plat for polystyrene 

Chemical Value Chain

Ineos Styrolution confirmed its decision to invest into a pilot plant for advanced recycling of polystyrene. The site will be set up in collaboration with Recycling Technologies in Swindon, U.K. It is expected to be operational in the second half of 2022.

December 5, 2021

Air Liquide is preparing Benoît Potier’s succession within the Executive Management as of June 1, 2022, in conjunction with the implementation of a new governance structure

Chemical Value Chain

The Air Liquide’s Board reviewed the Group’s leadership succession plan and approved the principle of a new form of governance. In this context, when the Board meets at the close of the 2022 Shareholders General Meeting, it will be asked to renew Benoît Potier’s term of office as Chairman of the Board of Directors and to appoint François Jackow to succeed him as Chief Executive Officer with effect from June 1, 2022.

Send this to a friend